Literature DB >> 29656365

Characterization of AAV vector particle stability at the single-capsid level.

Julien Bernaud1, Axel Rossi2, Anny Fis1, Lara Gardette1, Ludovic Aillot2, Hildegard Büning3, Martin Castelnovo4, Anna Salvetti5, Cendrine Faivre-Moskalenko6.   

Abstract

Virus families have evolved different strategies for genome uncoating, which are also followed by recombinant vectors. Vectors derived from adeno-associated viruses (AAV) are considered as leading delivery tools for in vivo gene transfer, and in particular gene therapy. Using a combination of atomic force microscopy (AFM), biochemical experiments, and physical modeling, we investigated here the physical properties and stability of AAV vector particles. We first compared the morphological properties of AAV vectors derived from two different serotypes (AAV8 and AAV9). Furthermore, we triggered ssDNA uncoating by incubating vector particles to increasing controlled temperatures. Our analyses, performed at the single-particle level, indicate that genome release can occur in vitro via two alternative pathways: either the capsid remains intact and ejects linearly the ssDNA molecule, or the capsid is ruptured, leaving ssDNA in a compact entangled conformation. The analysis of the length distributions of ejected genomes further revealed a two-step ejection behavior. We propose a kinetic model aimed at quantitatively describing the evolution of capsids and genomes along the different pathways, as a function of time and temperature. This model allows quantifying the relative stability of AAV8 and AAV9 particles.

Keywords:  Atomic force microscopy; Capsid disassembly; Genome uncoating; Stochastic forces

Mesh:

Year:  2018        PMID: 29656365      PMCID: PMC5928021          DOI: 10.1007/s10867-018-9488-5

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  23 in total

1.  Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.

Authors:  Clare E Thomas; Theresa A Storm; Zan Huang; Mark A Kay
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Optimal architectures of elongated viruses.

Authors:  Antoni Luque; Roya Zandi; David Reguera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

4.  Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus.

Authors:  X Xiao; J Li; R J Samulski
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Factors influencing recombinant adeno-associated virus production.

Authors:  A Salvetti; S Orève; G Chadeuf; D Favre; Y Cherel; P Champion-Arnaud; J David-Ameline; P Moullier
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

6.  Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity.

Authors:  Svenja Bleker; Florian Sonntag; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.

Authors:  Bernd Hauck; Wei Zhao; Katherine High; Weidong Xiao
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Comparative analysis of adeno-associated virus capsid stability and dynamics.

Authors:  Vamseedhar Rayaprolu; Shannon Kruse; Ravi Kant; Balasubramanian Venkatakrishnan; Navid Movahed; Dewey Brooke; Bridget Lins; Antonette Bennett; Timothy Potter; Robert McKenna; Mavis Agbandje-McKenna; Brian Bothner
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

9.  Buckling of spherical shells adhering onto a rigid substrate.

Authors:  S Komura; K Tamura; T Kato
Journal:  Eur Phys J E Soft Matter       Date:  2005-11-15       Impact factor: 1.624

10.  Thermal Stability as a Determinant of AAV Serotype Identity.

Authors:  Antonette Bennett; Saajan Patel; Mario Mietzsch; Ariana Jose; Bridget Lins-Austin; Jennifer C Yu; Brian Bothner; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Mol Ther Methods Clin Dev       Date:  2017-07-24       Impact factor: 6.698

View more
  14 in total

1.  Loading the dice: The orientation of virus-like particles adsorbed on titanate assisted organosilanized surfaces.

Authors:  Daniel Moreno-Cerrada; Chloe Rodríguez; Francisco Moreno-Madrid; Ekaterina Selivanovitch; Trevor Douglas; Pedro J de Pablo; Miguel Manso Silván
Journal:  Biointerphases       Date:  2019-01-28       Impact factor: 2.456

Review 2.  Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

Authors:  Maria Yanqing Chen; Susan S Butler; Weitong Chen; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-11-08

3.  rAAV Production and Titration at the Microscale for High-Throughput Screening.

Authors:  David Nathan Quan; Joseph Shiloach
Journal:  Hum Gene Ther       Date:  2021-09-07       Impact factor: 5.695

Review 4.  Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions.

Authors:  Jalish M Riyad; Thomas Weber
Journal:  Gene Ther       Date:  2021-03-03       Impact factor: 4.184

5.  Parvovirus B19 Uncoating Occurs in the Cytoplasm without Capsid Disassembly and It Is Facilitated by Depletion of Capsid-Associated Divalent Cations.

Authors:  Oliver Caliaro; Andrea Marti; Nico Ruprecht; Remo Leisi; Suriyasri Subramanian; Susan Hafenstein; Carlos Ros
Journal:  Viruses       Date:  2019-05-10       Impact factor: 5.048

6.  Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity.

Authors:  Axel Rossi; Léa Dupaty; Ludovic Aillot; Liang Zhang; Célia Gallien; Michael Hallek; Margarete Odenthal; Sahil Adriouch; Anna Salvetti; Hildegard Büning
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

7.  Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics.

Authors:  Laura Rodriguez-Estevez; Priyadarsini Asokan; Teresa Borrás
Journal:  Gene Ther       Date:  2019-10-14       Impact factor: 5.250

8.  rAAV Engineering for Capsid-Protein Enzyme Insertions and Mosaicism Reveals Resilience to Mutational, Structural and Thermal Perturbations.

Authors:  Rebecca C Feiner; Julian Teschner; Kathrin E Teschner; Marco T Radukic; Tobias Baumann; Sven Hagen; Yvonne Hannappel; Niklas Biere; Dario Anselmetti; Katja M Arndt; Kristian M Müller
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

9.  Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques.

Authors:  Liam Cole; Diogo Fernandes; Maryam T Hussain; Michael Kaszuba; John Stenson; Natalia Markova
Journal:  Pharmaceutics       Date:  2021-04-20       Impact factor: 6.321

10.  Effects of Thermally Induced Configuration Changes on rAAV Genome's Enzymatic Accessibility.

Authors:  Yinxia Xu; Ping Guo; Junping Zhang; Matthew Chrzanowski; Helen Chew; Jenni A Firrman; Nianli Sang; Yong Diao; Weidong Xiao
Journal:  Mol Ther Methods Clin Dev       Date:  2020-06-10       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.